Solobacterium moorei

From IDWiki
Solobacterium moorei


Background

  • Non-spore-forming strictly anaerobic Gram-positive bacillus
  • Typically isolated from human feces and difficult to cluster

Clinical Manifestations

  • Associated with halitosis and odontogenic infections
  • Rare bacteremia, particularly in immunocompromised people12
  • Rare wound infections

Management

  • Appears to be generally susceptible to most antibiotics, including penicillin, piperacillin-tazobactam, clindamycin, metronidazole, meropenem, moxifloxacin, tigecycline, and vancomycin132

References

  1. a b  G. Detry, D. Pierard, K. Vandoorslaer, G. Wauters, V. Avesani, Y. Glupczynski. Septicemia due to Solobacterium moorei in a patient with multiple myeloma. Anaerobe. 2006;12(3):160-162. doi:10.1016/j.anaerobe.2006.04.002.
  2. a b  Rune Micha Pedersen, Hanne Marie Holt, Ulrik Stenz Justesen. Solobacterium moorei Bacteremia: Identification, Antimicrobial Susceptibility, and Clinical Characteristics. Journal of Clinical Microbiology. 2011;49(7):2766-2768. doi:10.1128/jcm.02525-10.
  3. ^  

    Guili Zheng, Paula H. Summanen, David Talan, Robert Bennion, Marie-Claire Rowlinson, Sydney M. Finegold. Phenotypic and Molecular Characterization of

               Solobacterium moorei
               Isolates from Patients with Wound Infection. Journal of Clinical Microbiology. 2010;48(3):873-876. doi:10.1128/jcm.01381-09.